ReviewRenal failure2025
PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients.
Bohan Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewRenal failure2025
Bohan Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.